Rukunin wani kamfani na Japan wanda Philip Morris International ke marawa baya yana shirin ƙaddamar da rigakafin Covid-19 na farko a duniya wanda ke da arha kuma mai sauƙin jigilar kayayyaki da adanawa fiye da jabs na al'ada.
Toshifumi Tada, shugaban ci gaban kasuwancin rigakafin a Mitsubishi Tanabe Pharma, ya ce reshenta na Medicago zai nemi amincewar Kanada ga dan takararta na rigakafin da aka yi daga shuka daga dangin taba a karshen wannan shekara.
Kungiyar masu samar da magunguna ta Osaka tana tsammanin bukatar duniya na allurar rigakafin cutar ta Covid ta ci gaba da kasancewa mai karfi yayin da sabbin nau'ikan cutar sankara ke ci gaba da bulla, yana ba ta damar shiga cikin kasuwar da 'yan gaba kamar Pfizer, Moderna, da AstraZeneca suka mamaye.
Tada ya ce "Kamar yadda yake da mura na yanayi, ba ma tsammanin bukatar (alurar rigakafin Covid) za ta bace ba zato ba tsammani, kuma har yanzu akwai rashin tabbas game da bambance-bambancen da ke fitowa," in ji Tada. "Mun yi imanin akwai darajar faɗaɗa zaɓuɓɓukan rigakafin."
Babu wata allurar rigakafin da aka amince da ita don amfani da dan adam, amma masu goyon bayan fasahar sun ce irin wadannan alluran rigakafin suna da kyau saboda ganyen tsiro na girma da sauri, yana rage ayyukan masana'antu da rage farashi. Saurin samarwa, sun kara da cewa, yana kuma sauƙaƙa daidaitawa don yaƙar sabbin nau'ikan.